Your browser doesn't support javascript.
loading
Study of effective components and molecular mechanism for Guizhi Fuling formula treatment of dysmenorrhea, pelvic inflammatory disease and uterine fibroids / 中国中药杂志
China Journal of Chinese Materia Medica ; (24): 999-1004, 2015.
Article Dans Chinois | WPRIM | ID: wpr-246162
ABSTRACT
In this study, the active components and potential molecular .mechanism of Guizhi Fuling formula in treatment on dysmenorrhea, pelvic inflammation, and hysteromyoma were investigated using network pharmacological methods. Sterols and pentacyclic triterpenes, with high moleculal network degree, revealed promising effects on anti-inflammatory, analgesic, anti-tumor, and immune-regulation, according to D-T network analysis. On the other hand, the targets with high degree were involved in inflammatory, coagulation, angiopoiesis, smooth muscle contraction, and cell reproduction, which showed the novel function in anti-dysmenorrhea, pelvic inflammation, and hysteromyoma. Furthermore, the formula was indicated to play a key role in smooth muscle proliferation, inhibition of new vessels, circulation improvement, reduction of hormone secretion, alleviation of smooth muscle, block of arachidonic acid metabolism, and inflammation in uterus. Thus, the main mechanism of Guizhi Fuling formula was summarized. In conclusion, Guizhi Fuling formula was proven to alleviated dysmenorrhea, pelvic inflammation, and hysteromyoma by acting on multiple targets through several bioactive compounds, regulating 21 biological pathways.
Sujets)
Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) Sujet Principal: Médicaments issus de plantes chinoises / Maladie inflammatoire pelvienne / Utilisations thérapeutiques / Traitement médicamenteux / Dysménorrhée / Réseaux de régulation génique / Génétique / Léiomyome / Métabolisme Limites du sujet: Femelle / Humains langue: Chinois Texte intégral: China Journal of Chinese Materia Medica Année: 2015 Type: Article

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) Sujet Principal: Médicaments issus de plantes chinoises / Maladie inflammatoire pelvienne / Utilisations thérapeutiques / Traitement médicamenteux / Dysménorrhée / Réseaux de régulation génique / Génétique / Léiomyome / Métabolisme Limites du sujet: Femelle / Humains langue: Chinois Texte intégral: China Journal of Chinese Materia Medica Année: 2015 Type: Article